Previous close | 0.2335 |
Open | 0.2335 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.2320 - 0.2340 |
52-week range | 0.1790 - 0.9129 |
Volume | |
Avg. volume | 128,036 |
Market cap | 11.08M |
Beta (5Y monthly) | 2.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PARIS & BOULDER, Colo., April 17, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its full-year 2023 financial results, for the financial year ending December 31, 2023, as approved by the Board of Directors on April 17, 2024, and its first quarter 2024 sales.
PARIS & BOULDER, Colorado, March 05, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) unique sensing technology using electrical conductivity local measurement in real time to secure and streamline the placement of bone implants, today announces a key progress in its Chinese regulatory plan with the submission to the Chinese authorities (NMPA) of a file seeking clearance renewal for the currently available range of
PARIS & BOULDER, Colo., February 06, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) unique sensing technology using electrical conductivity local measurement in real time to secure and streamline the placement of bone implants, today announces having reached 100,000 surgeries secured with the DSG technology and having passed 30 scientific publications.